Pulse wave velocity (PWV) reflects arterial stiffness and is an independent predictor of cardiovascular mortality and morbidity. However, because it is closely related to blood pressure (BP), PWV is an imperfect measure for evaluating the effects of anti-hypertensive drugs on arterial wall properties. To clarify the effect of benidipine on arterial properties, we first derived the regression line between BP and PWV changes in a short-term experiment. Using this line, we evaluated the long-term effect of benidipine on PWV changes. In the short-term experiment, 29 participants were intravenously administered nicardipine for 90 min. Maximum decreases of brachial-ankle PWV (baPWV) were plotted against the corresponding decreases in BP. In the long-term experiment, 9 hypertensive patients were treated with benidipine for 1 year, during which BP and baPWV were monitored. After 1 year, benidipine was suspended for 2 weeks, and BP and baPWV were reevaluated. In the short-term experiment, PWV was dependent on BP only, and the equation of the regression line was ΔPWV (cm/s) =10.114 × ΔMBP (mmHg) (r=0.913) or ΔPWV (%) =0.719 × ΔMBP (%) (r=0.926). In the long-term therapy, benidipine treatment achieved stable BP control within 3 months; the real PWV decreases (r-PWV) were almost identical to the PWV decrease estimated (e-PWV) from BP lowering at 3 months. However, r-PWV exceeded e-PWV after 6 months. Relative BP and PWV improvements compared to the control were maintained 2 weeks after suspension of benidipine. In conclusion, long-term benidipine administration improves arterial wall properties beyond what can be accounted for by changes in BP.
Laurent S, Boutouyrie P, Asmar R, et al: Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37: 1236–1241.
Blacher J, Asmar R, Djane S, London GM, Safar ME : Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 1999; 33: 1111–1117.
Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London ME : Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 2001; 103: 987–992.
Kita T, Kitamura K, Hashida S, Morishita K, Eto T : Plasma adrenomedullin is closely correlated with pulse wave velocity in middle-aged and elderly patients. Hypertens Res 2003; 26: 887–893.
Imanishi R, Seto S, Toda G, et al: High brachial-ankle pulse wave velocity is an independent predictor of the presence of coronary artery disease in men. Hypertens Res 2004; 27: 71–78.
Koji Y, Tomiyama H, Ichihashi H, et al: Comparison of ankle-brachial pressure index and pulse wave velocity as markers of the presence of coronary artery disease in subjects with a high risk of atherosclerotic cardiovascular disease. Am J Cardiol 2004; 94: 868–872.
Munakata M, Ito N, Nunokawa T, Yoshinaga K : Utility of automated brachial ankle pulse wave velocity measurements in hypertensive patients. Am J Hypertens 2003; 16: 653–657.
Matsui Y, Kario K, Ishikawa J, Eguchi K, Hoshide S, Shimada K : Reproducibility of arterial stiffness indices (pulse wave velocity and augmentation index) simultaneously assessed by automated pulse wave analysis and their associated risk factors in essential hypertensive patients. Hypertens Res 2004; 27: 851–857.
Munakata M, Sakuraba J, Tayama J, et al: Higher brachial-ankle pulse wave velocity is associated with more advanced carotid atherosclerosis in end-stage renal disease. Hypertens Res 2005; 28: 9–14.
Ichihara A, Hayashi M, Koura Y, Toda Y, Hirota N, Saruta T : Long-term effects of intensive blood pressure lowering on arterial wall stiffness in hypertensive patients. Am J Hypertens 2003; 16: 959–965.
Munakata M, Nagasaki A, Nunokawa T, et al: Effects of valsartan and nifedipine coat-core on systemic arterial stiffness in hypertensive patients. Am J Hypertens 2004; 17: 1050–1055.
Agata J, Nagahara D, Kinoshita S, et al: Angiotensin II receptor blocker prevents increased arterial stiffness in patients with essential hypertension. Circ J 2004; 68: 1194–1198.
Pitt B, Byington RP, Furberg CD, et al, PREVENT Investigators: Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. Circulation 2000; 102: 1503–1510.
Zanchetti A, Bond MG, Henning M, et al: Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial. Circulation 2002; 106: 2422–2427.
Nissen SE, Tuzcu EM, Libby P, et al: Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. JAMA 2004; 292: 2217–2225.
Dohi Y, Kojima M, Sato K : Benidipine improves endothelial function in renal resistance arteries of hypertensive rats. Hypertension 1996; 28: 58–63.
Kobayashi N, Kobayashi K, Kouno K, Yagi S, Matsuoka H : Effect of benidipine on microvascular remodeling and coronary flow reserve in two-kidney, one clip Goldblatt hypertension. J Hypertens 1997; 15: 1285–1294.
Yamashita T, Kawashima S, Ozaki M, et al: A calcium channel blocker, benidipine, inhibits intimal thickening in the carotid artery of mice by increasing nitric oxide production. J Hypertens 2001; 19: 451–458.
Wilkinson IB, Mohammad NH, Tyrrell S, et al: Heart rate dependency of pulse pressure amplification and arterial stiffness. Am J Hypertens 2002; 15: 24–30.
Benetos A, Adamopoulos C, Bureau J-M, et al: Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over 6-year period. Circulation 2002; 105: 1202–1207.
National Intervention Cooperative Study in Elderly Hypertension Study Group : Randomized double-blind comparison of a calcium antagonist and a diuretic in elderly hypertensives. Hypertension 1999; 34: 1129–1133.
Tsukiyama H, Kikawada R, Osada H, et al: Safety and efficacy of long-term therapy with benidipine in aged hypertensive patients. Geriat Med 1997; 35: 989–1007 ( in Japanese).
Ito A, Fukumoto Y, Shimokawa H : Changing characteristics of patients with vasospastic angina in the era of new calcium channel blockers. J Cardiovasc Pharmacol 2004; 44: 480–485.
Hayashi K, Ozawa Y, Fujiwara K, Wakino S, Kumagai H, Saruta T : Role of actions of calcium antagonists on efferent arterioles—with special references to glomerular hypertension. Am J Nephrol 2003; 23: 229–244.
Kobayashi N, Nakano S, Mori Y, Kobayashi T, Tsubokou Y, Matsuoka H : Benidipine inhibits expression of ET-1 and TGF-β1 in Dahl salt-sensitive hypertensive rats. Hypertens Res 2001; 24: 241–250.
Yasunari K, Maeda K, Nakamura M, Watanabe T, Yoshikawa J : Benidipine, a long-acting calcium channel blocker, inhibits oxidative stress in polymorphonuclear cells in patients with essential hypertension. Hypertens Res 2005; 28: 107–112.
Pai JK, Pischon T, Ma J, et al: Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 2004; 351: 2599–2610.
Ridker PM, Cannon CP, Morrow D, et al: C-reactive protein levels and outcomes after statin therapy. N Engl J Med 2005; 352: 20–28.
Takase H, Toriyama T, Sugiyama M, et al: Effect of nifedipine on C-reactive protein levels in the coronary sinus and on coronary blood flow in response to acetylcholine in patients with stable angina pectoris having percutaneous coronary intervention. Am J Cardiol 2005; 95: 1235–1237.
About this article
Cite this article
Kita, T., Suzuki, Y., Eto, T. et al. Long-Term Anti-Hypertensive Therapy with Benidipine Improves Arterial Stiffness over Blood Pressure Lowering. Hypertens Res 28, 959–964 (2005). https://doi.org/10.1291/hypres.28.959
- pulse wave velocity
- blood pressure